Northern Oil And Gas (NOG) Announces 6.5M Share Offering

Northern Oil and Gas, Inc. (NYSE: NOG) (the “Company” or “NOG”) announced today an underwritten public offering of 6,500,000 shares of its common stock (the “Offering”). Additionally, the Company has granted the underwriters a 30-day option to purchase up to an additional 975,000 shares from the Company.

The Company intends to use the net proceeds from the Offering for general corporate purposes, which will include the repayment of a portion of the outstanding borrowings under its revolving credit facility.

Citigroup is acting as the sole book-running manager for the Offering. The underwriters may offer the shares of common stock from time to time for sale in one or more transactions on the New York Stock Exchange, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices.

The Offering will be made only by means of a prospectus supplement and the accompanying base prospectus, which was filed as part of an effective shelf registration statement filed with the Securities and Exchange Commission (“SEC”) on Form S-3. Copies of the preliminary prospectus supplement and accompanying base prospectus relating to the Offering, as well as copies of the final prospectus supplement, once available, may be obtained on the SEC’s website at www.sec.gov or by contacting Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 (Tel: 800-831-9146).

This press release does not constitute an offer to sell, a solicitation to buy or an offer to purchase or sell any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

You May Also Be Interested In

• Amylyx prices $500M stock offering at $35.50 per share
• Edesa Biotech prices $25M public offering on Nasdaq
• Andersen prices secondary offering of 4.28M shares at $44 each